Drugs / Lactobacillus helveticusRosell®-52
last change Feb 2021 re-read 2 minutes ago

Lactobacillus helveticusRosell®-52

Developed for
major depressive disorder
Investigated by
Medical University of Lublin · Sanprobi Sp. z o.o., Sp. k., Szczecin, Poland

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT03877393 Apr 2019 → Jul 2020 major depressive disorder Medical University of Lublin Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Lactobacillus helveticusRosell-52 “one capsule containing the probiotic mixture powder (Sanprobi Stress; Sanprobi sp. z o.o., sp.k., Szczecin, Poland) in the amount of 3 × 10\^9 colony forming units (CFU) per...” NCT03877393
Route Oral “The participants will be asked to consume supplements before breakfast.” NCT03877393